CorMedix Inc. Revenue 2012–2025
CorMedix Inc. annual/quarterly revenue history and growth rate from 2012 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- CorMedix Inc. revenue for the quarter ending March 31, 2026 was 127.4 M, a 226.05% increase year-over-year.
- CorMedix Inc. revenue for the twelve months ending March 31, 2026 was 310.5 M, a 2426.55% increase year-over-year.
- CorMedix Inc. annual revenue for 2025 was 311.7 M, a 617.03% increase from 2024.
- CorMedix Inc. annual revenue for 2024 was 43.5 M, a 66362.82% increase from 2022.
- CorMedix Inc. annual revenue for 2022 was 65408, a 65.74% decrease from 2021.
- CorMedix Inc. annual revenue for 2021 was 190936.
CorMedix Inc. (CRMD) — Frequently Asked Questions
CorMedix Inc. (CRMD) is a publicly traded US company. It has a market capitalization of $716,347.36. In fiscal 2025 it reported revenue of $312M and net income of $163M. Explore CRMD's stock price, financial statements, earnings history, margins and key ratios below.
What is CorMedix Inc.'s market cap?
CorMedix Inc. (CRMD) has a market capitalization of $716,347.36.
What is the CRMD stock price?
CRMD trades at $8.92 (+1.71% on the day).
How much revenue does CorMedix Inc. make?
CorMedix Inc. reported revenue of $312M in fiscal 2025.
Is CRMD profitable?
In fiscal 2025, CorMedix Inc. reported net income of $163M.